Avanos Medical Inc (NYSE: AVNS) has reported E.P.S. of $0.09 for its second fiscal quarter (ending June 30) versus $-0.09 for the same period a year ago. For the latest four quarters through June 30, E.P.S. were $0.15 compared to $0.19 a year ago.
Recent Price Action
On 7/31/24, Avanos Medical Inc (NYSE: AVNS) stock enjoyed a large increase of 4.2%, closing at $23.92. Moreover, trading volume in this advance was above average at 131% of normal. The stock has been weak relative to the market over the last nine months but has risen 5.4% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to exceed the cost of capital, AVNS is expected to be a modest Value Builder.
Avanos Medical has a current Value Trend Rating of C (Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing contradictory signals. Avanos Medical has a slightly positive Appreciation Score of 64 but a slightly negative Power Rating of 34, resulting in the Neutral Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment